Site-selective protein modification via disulfide rebridging for fast tetrazine/trans-cyclooctene bioconjugation

Org Biomol Chem. 2020 Feb 14;18(6):1140-1147. doi: 10.1039/c9ob02687h. Epub 2020 Jan 23.

Abstract

An inverse electron demand Diels-Alder reaction between tetrazine and trans-cyclooctene (TCO) holds great promise for protein modification and manipulation. Herein, we report the design and synthesis of a tetrazine-based disulfide rebridging reagent, which allows the site-selective installation of a tetrazine group into disulfide-containing peptides and proteins such as the hormone somatostatin (SST) and the antigen binding fragment (Fab) of human immunoglobulin G (IgG). The fast and efficient conjugation of the tetrazine modified proteins with three different TCO-containing substrates to form a set of bioconjugates in a site-selective manner was successfully demonstrated for the first time. Homogeneous, well-defined bioconjugates were obtained underlining the great potential of our method for fast bioconjugation in emerging protein therapeutics. The formed bioconjugates were stable against glutathione and in serum, and they maintained their secondary structure. With this work, we broaden the scope of tetrazine chemistry for site-selective protein modification to prepare well-defined SST and Fab conjugates with preserved structures and good stability under biologically relevant conditions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cyclooctanes / chemistry
  • Cyclooctanes / metabolism*
  • Disulfides / chemical synthesis
  • Disulfides / chemistry
  • Disulfides / metabolism*
  • Heterocyclic Compounds / chemistry*
  • Humans
  • Immunoglobulin G / chemistry
  • Immunoglobulin G / metabolism*
  • Models, Molecular
  • Molecular Structure
  • Protein Processing, Post-Translational

Substances

  • Cyclooctanes
  • Disulfides
  • Heterocyclic Compounds
  • Immunoglobulin G